BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9121264)

  • 1. Familial non-VHL non-papillary clear-cell renal cancer.
    Teh BT; Giraud S; Sari NF; Hii SI; Bergerat JP; Larsson C; Limacher JM; Nicol D
    Lancet; 1997 Mar; 349(9055):848-9. PubMed ID: 9121264
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited renal cell carcinoma.
    Maher ER
    Br J Urol; 1996 Oct; 78(4):542-5. PubMed ID: 8944511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
    Richard S; Beroud C; Joly D; Chretien Y; Benoit G
    Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Hippel-Lindau gene mutations in human and rodent renal tumors--association with clear cell phenotype.
    Gnarra JR
    J Natl Cancer Inst; 1998 Nov; 90(22):1685-7. PubMed ID: 9827515
    [No Abstract]   [Full Text] [Related]  

  • 5. VHL gene mutation and clear-cell renal carcinomas.
    Knudson AG
    Cancer J Sci Am; 1995; 1(3):180-1. PubMed ID: 9166471
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations of the VHL tumour suppressor gene in renal carcinoma.
    Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
    Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the genes for kidney cancer.
    Linehan WM
    Cancer Biol Ther; 2006 Jun; 5(6):696-9. PubMed ID: 16775424
    [No Abstract]   [Full Text] [Related]  

  • 8. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
    Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
    Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing.
    Shah DR; Hoeksema J; Korbet SM
    Clin Nephrol; 2000 Mar; 53(3):216-21. PubMed ID: 10749302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic basis of cancer of the kidney.
    Sudarshan S; Linehan WM
    Semin Oncol; 2006 Oct; 33(5):544-51. PubMed ID: 17045083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial cerebellar hemangioblastoma associated with renal cell carcinoma].
    Kubo Y; Waga S; Kojima T; Itou H; Matsubara T
    Rinsho Shinkeigaku; 1987 Nov; 27(11):1388-94. PubMed ID: 3447798
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
    Chen F; Kishida T; Duh FM; Renbaum P; Orcutt ML; Schmidt L; Zbar B
    Cancer Res; 1995 Nov; 55(21):4804-7. PubMed ID: 7585510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.
    Smits KM; Schouten LJ; Hudak E; Verhage B; van Dijk BA; Hulsbergen-van de Kaa CA; Goldbohm RA; Oosterwijk E; van den Brandt PA
    Ann Epidemiol; 2010 May; 20(5):401-4. PubMed ID: 20382342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.
    Cascón A; Escobar B; Montero-Conde C; Rodríguez-Antona C; Ruiz-Llorente S; Osorio A; Mercadillo F; Letón R; Campos JM; García-Sagredo JM; Benítez J; Malumbres M; Robledo M
    Hum Mutat; 2007 Jun; 28(6):613-21. PubMed ID: 17311301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A family of von Hippel-Lindau disease with renal cell carcinoma--case report and review of the literature].
    Ito F; Uda M; Toma H
    Hinyokika Kiyo; 1991 Feb; 37(2):157-62. PubMed ID: 2048495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.
    Poston CD; Jaffe GS; Lubensky IA; Solomon D; Zbar B; Linehan WM; Walther MM
    J Urol; 1995 Jan; 153(1):22-6. PubMed ID: 7966777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
    Gnarra JR; Lerman MI; Zbar B; Linehan WM
    Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.